Australia's Proteomics rises on developing potential blood test to detect endometriosis

Proteomics International Laboratories

01/08/2022 06:43

** Shares of medical tech co Proteomics International
Laboratories Ltd  PIQ.AX  rise as much as 7.4% to A$0.940, their
highest since June 9
    ** Co says an early version of its potential blood test for
endometriosis has successfully detected up to 78% of people with
the condition  urn:newsml:reuters.com:*:nASX1mZ3Sv
    ** Endometriosis is a condition that occurs when tissue
similar to the lining of uterus grows into other parts of the
body 
    ** Says the current gold standard for detection is an
invasive laparoscopy, a surgical procedure
    ** Co expects that additional analysis to refine and
validate the diagnostic results will be completed in stages over
the next two-six months
    ** Shares mark their biggest intraday pct gain since June 30
    ** Volumes 2 times the 30-day average of 80,718 shares
    ** As of last close, stock down 28% this year

 (Reporting by Himanshi Akhand in Bengaluru)
 ((Himanshi.Akhand@thomsonreuters.com;))